Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2007
Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effectsJessica E Malberg, Brian Platt, Stacey J Sukoff Rizzo, et al.European Journal of Pharmacology|August 5, 2008
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmissionBrian A Hoshaw, Tiffany I Hill, James J Crowley, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 20, 2007
cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant responseTamar L Gur, Alana C Conti, Jessica Holden, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding proteinShin Nakagawa, Ji-Eun Kim, Rena Lee, et al.The International Journal of Neuropsychopharmacology|May 14, 2009
5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in ratsStacey J Sukoff Rizzo, Claudine Pulicicchio, Jessica E Malberg, et al.Journal of Medicinal Chemistry|March 17, 2009
Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like actionSung Jin Cho, Niels H Jensen, Toru Kurome, et al.Psychopharmacology|January 19, 2006
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implicationsRobert H Ring, Jessica E Malberg, Lisa Potestio, et al.Pharmacology & Therapeutics|October 3, 2006
Differentiating antidepressants of the future: efficacy and safetySharon Rosenzweig-Lipson, Chad E Beyer, Zoë A Hughes, et al.Psychopharmacology|February 14, 2007
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodentsSharon Rosenzweig-Lipson, Annmarie Sabb, Gary Stack, et al.Psychopharmacology|March 4, 2008
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disordersSarah K Leonard, Jason M Dwyer, Stacey J Sukoff Rizzo, et al.Pageof 2